New in time for #AACR26 💡 Results have demonstrated, possibly for the first time, the potential of intratumoral C. tropicalis burden as a...

Back to meeting Original

Back to meeting

AACR 2026 现场信号· @ · X·2026-04-22 06:09· 2026-04-22Score60

#COLORECTALCANCER

Reading

KRAS / RAS 靶向 — 从平台化到 Ph3 验证

Deep dive

发生了什么

City of Hope的GI肿瘤医学总监Pashtoon Kasi将在AACR26会议上展示Clover试验的突破性发现，地点为Section 41、Poster 14，时间为下午2点至5点。

为什么重要

据报道该试验为II期研究^[1]，聚焦微卫星稳定型结直肠癌^[2]，并涉及一种靶向CCR5的Lironi MAP分子^[3]，这些数据可能为难治性结直肠癌提供新的治疗思路。

还缺什么

完整的疗效数据、安全性概况及生物标志物分析尚未公开，待会议墙报发布后进一步解读；后续需关注该试验是否推进至III期注册研究及监管沟通进展，目前均待确认。

References

1.Highlights from AACR 2026 Part 3 · oncodaily.com 2026
2.Pashtoon Kasi MD, MS · x.com 2026
3.#aacr26 #colorectalcancer | Pashtoon Kasi · linkedin.com 2026

Body · original

New in time for #AACR26 💡 Results have demonstrated, possibly for the first time, the potential of intratumoral C. tropicalis burden as a novel prognostic biomarker for recurrence and mortality in patients with #ColorectalCancer.

https://t.co/RGCsfE5nTB

@OncoAlert #CRCSM https://t.co/BUilDYr6UY

Heat 12 · 7 likes · 0 replies · 5 reposts

Source: AACR 2026 现场信号 · x.com